
Chengdu
300841.SZChengdu Kanghua Biological Products Co., Ltd. Price (300841.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
133,747,266
(0.1703)%
Cash Flow Statement
Chengdu Kanghua Biological Products Co., Ltd.Currency: CNY
YEAR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||||||
Net Income | 11.70M
+0% |
6.66M
-43% |
74.46M
+1,018% |
154.14M
+107% |
186.69M
+21% |
408.05M
+119% |
829.48M
+103% |
598.07M
-28% |
509.22M
-15% |
||||||||||
Depreciation And Amortiz... | 10.19M | 9.97M | 9.72M | 9.34M | 9.08M | 12.26M | 16.53M | 32.57M | 61.77M | ||||||||||
Deferred Income Tax | 3.23M | -1,057,300.00 | 4.45M | -240,100.00 | 337.10k | 123.37k | -1,857,019.00 | 6.27M | 0.00 | ||||||||||
Stock-Based Compensat... | 0.00 | 0.00 | 0.00 | 21.87M | 18.66M | 10.76M | 8.90M | 1.86M | 0.00 | ||||||||||
Change In Working Capital | |||||||||||||||||||
Accounts Receivables | -7,036,800.00 | -42,135,700.00 | -25,950,500.00 | -154,051,100.00 | -25,860,478.00 | -102,151,496.00 | -535,228,536.00 | -448,907,823.00 | -113,841,227.00 | ||||||||||
Accounts Payables | -5,760,900.00 | 14.45M | 27.11M | 23.29M | 4.49M | 41.69M | 124.72M | 61.35M | 95.70M | ||||||||||
Inventory | -20,264,500.00 | -6,675,000.00 | -4,139,769.91 | -6,337,154.06 | -16,036,476.66 | -1,256,982.15 | -57,531,777.44 | -56,859,393.30 | -21,520,709.00 | ||||||||||
Other Working Capital | -9,571,000.00 | -28,740,700.00 | 5.61M | -131,003,894.14 | 337.10k | 123.37k | -1,857,019.77 | 6.27M | 0.00 | ||||||||||
Other Non-Cash Items | 14.45M | 21.44M | 4.31M | 31.22M | 24.04M | 10.85M | -245,783,402.79 | 2.49M | 42.66M | ||||||||||
Net Cash Provided By Op... | 6.51M
+0% |
2.64M
-59% |
89.96M
+3,303% |
57.35M
-36% |
182.73M
+219% |
369.56M
+102% |
130.33M
-65% |
194.99M
+50% |
573.98M
+194% |
||||||||||
Investing Activities | |||||||||||||||||||
Investments In Propert... | -3,070,523.50 | -1,855,466.39 | -4,531,273.74 | -34,580,561.46 | -24,035,200.57 | -135,668,447.72 | -314,939,333.31 | -419,226,180.12 | -157,274,690.00 | ||||||||||
Acquisitions Net | 0.00 | 0.00 | 148.07k | 3.92k | 66.09k | 135.72M | 10.00k | 1.57k | 0.00 | ||||||||||
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -592,500,000.00 | -850,250,000.00 | -210,000,000.00 | -56,500,000.00 | ||||||||||
Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 286.72M | 963.65M | 216.77M | 50.35M | ||||||||||
Other Investing Activities | -3,070,523.50 | -1,855,466.39 | 148.07k | 3.92k | 0.26 | -135,668,446.76 | 0.11 | 0.58 | 36.59k | ||||||||||
Net Cash Used For Inv... | -3,070,523.50
+0% |
-1,855,466.39
-40% |
-4,383,205.77
+136% |
-34,576,639.13
+689% |
-23,969,109.31
-31% |
-441,397,949.48
+1,742% |
-201,528,340.20
-54% |
-412,458,856.54
+105% |
-163,389,350.00
-60% |
||||||||||
Financing Activities | |||||||||||||||||||
Debt Repayment | 0.00 | 0.00 | -221,663,010.00 | 11.50M | -9,000,000.00 | -10,000,000.00 | 0.00 | 125.93M | 64.83M | ||||||||||
Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 985.99M | 0.00 | 67.21M | 0.00 | ||||||||||
Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -985,985,000.00 | -55,884,259.00 | -67,213,280.00 | 0.00 | ||||||||||
Dividends Paid | 0.00 | 0.00 | -21,269,631.90 | -5,941,644.90 | -532,838.75 | -230,791.67 | -90,000,000.00 | -133,776,000.00 | -71,634,449.00 | ||||||||||
Other Financing Activities | 0.00 | 0.00 | 210.13M | 1.45M | 0.75 | 985.75M | -57,396,459.02 | -65,714,412.47 | -312,311.00 | ||||||||||
Net Cash Used/Provide... | 0.00
+0% |
0.00
+0% |
-32,807,639.97
+0% |
7.00M
-121% |
-9,532,838.75
-236% |
975.75M
-10,336% |
-147,396,459.02
-115% |
-73,564,929.47
-50% |
-7,117,363.00
-90% |
||||||||||
Effect Of Forex Changes... | 13.22k | 7.97k | -36,828.87 | -626.89 | 48.58k | -62,181.34 | -13,554.58 | 112.98k | -69,074.00 | ||||||||||
Net Change In Cash | 3.45M | 795.85k | 52.73M | 29.78M | 149.28M | 903.86M | -218,612,694.00 | -290,920,251.00 | 403.41M | ||||||||||
Cash At Beginning Of Per... | 5.60M | 9.05M | 9.85M | 62.58M | 92.36M | 241.63M | 1.15B | 926.88M | 635.96M | ||||||||||
Cash At End Of Period | 9.05M | 9.85M | 62.58M | 92.36M | 241.63M | 1.15B | 926.88M | 635.96M | 1.04B | ||||||||||
Additional Metrics: | |||||||||||||||||||
Operating Cash Flow | 6.51M | 2.64M | 89.96M | 57.35M | 182.73M | 369.56M | 130.33M | 194.99M | 573.98M | ||||||||||
Capital Expenditure | -3,070,523.50 | -1,855,466.39 | -4,531,273.74 | -34,580,561.46 | -24,035,200.57 | -135,668,447.72 | -314,939,333.31 | -419,226,180.12 | -157,274,693.00 | ||||||||||
Free Cash Flow | 3.43M
+0% |
787.83k
-77% |
85.43M
+10,743% |
22.77M
-73% |
158.69M
+597% |
233.90M
+47% |
-184,613,674.31
-179% |
-224,235,627.12
+21% |
416.71M
-286% |